AstraZeneca to buy US-based CinCor Pharma in $1.8 bln deal https://ift.tt/5lWa2E8

AstraZeneca said it will pay $26 per CinCor share in cash, a premium of nearly 121 per cent to the stock's closing price on Friday.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/uazBC6o
Share:

No comments:

Post a Comment

Search This Blog

Powered by Blogger.

Labels

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.